Epigenetic alterations in ultraviolet radiation-induced skin carcinogenesis: Interaction of bioactive dietary components on epigenetic targets

Photochemistry and Photobiology

Volumn 88, Issue 5, 2012, Pages 1066-1074

  Katiyar, Santosh K ^a,b   Singh, Tripti ^b   Prasad, Ram ^b   Sun, Qian ^b   Vaid, Mudit ^b  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; CATECHIN; PROANTHOCYANIDIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; CELL TRANSFORMATION; CONFERENCE PAPER; DIET; DNA METHYLATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; MELANOMA; METABOLISM; RADIATION EXPOSURE; SKIN; SKIN TUMOR; ULTRAVIOLET RADIATION;

ANIMALS; BIOLOGICAL AGENTS; CATECHIN; CELL TRANSFORMATION, NEOPLASTIC; DIET; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; MELANOMA; PROANTHOCYANIDINS; SKIN; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

ANIMALIA; VITACEAE;

EID: 84865965354     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2011.01020.x     Document Type: Conference Paper

References (69)

1. O'Shaughnessy, J. A., G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, W. G. Nelson, F. L. Meyskens, D. S. Alberts, M. Follen, A. K. Rustgi, V. Papadimitrakopoulou, P. T. Scardino, A. F. Gazdar, L. W. Wattenberg, M. B. Sporn, W. A. Sakr, S. M. Lippman, and, D. Von Hoff, (2002) Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development. Recommendations of the American Association for Cancer Research task force on the treatment and prevention of intraepithelial neoplasia. Clin. Cancer Res. 8, 314-346. (Pubitemid 34193948)
2. Housman, T. S., S. R. Feldman, P. M. Williford, A. B. Fleischer Jr, N. D. Goldman, J. M. Acostamadiedo, and, G. J. Chen, (2003) Skin cancer is among the most costly of all cancers to treat for the Medicare population. J. Am. Acad. Dermatol. 48, 425-429. (Pubitemid 36337080)
3. Jones, P. A., and, S. B. Baylin, (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428. (Pubitemid 34587077)
4. Laird, P. W., and, R. Jaenisch, (1996) The role of DNA methylation in cancer genetic and epigenetics. Annu. Rev. Genet. 30, 441-464. (Pubitemid 27015267)
5. Baylin, S. B., and, J. G. Herman, (2000) DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet. 16, 168-174. (Pubitemid 30169152)
6. Goodman, J. I., and, R. E. Watson, (2002) Altered DNA methylation: A secondary mechanism involved in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 42, 501-525. (Pubitemid 34160534)
7. Counts, J. L., and, J. I. Goodman, (1995) Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83, 13-15.
8. Zingg, J. M., and, P. A. Jones, (1997) Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 18, 869-882. (Pubitemid 28132329)
9. Jenuwein, T., and, C. D. Allis, (2001) Translating the histone code. Science 293, 1074-1080. (Pubitemid 32758077)
10. Wade, P. A., (2001) Methyl CpG-binding proteins and transcriptional repression. Bioessays 23, 1131-1137.
11. Bird, A. P., and, A. P. Wolffe, (1999) Methylation-induced repression-belts, braces, and chromatin. Cell 99, 451-454. (Pubitemid 129746827)
12. Ng, H. H., P. Jeppesen, and, A. Bird, (2000) Active repression of methylated genes by the chromosomal protein MBD1. Mol. Cell. Biol. 20, 1394-1406. (Pubitemid 30069259)
13. Egger, G., G. Liang, A. Aparicio, and, P. A. Jones, (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463. (Pubitemid 38715140)
14. Ehrlich, M., (2000) DNA methylation in cancer: Too much, but also too little. Oncogene 21, 5400-5413.
15. Jones, P. A., and, P. W. Laird, (1999) Cancer epigenetics comes of age. Nat. Genet. 21, 163-167. (Pubitemid 29070360)
16. Herman, J. G., and, S. B. Baylin, (2003) Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042-2054. (Pubitemid 37448928)
17. Jones, P. A., (2002) DNA methylation and cancer. Oncogene 21, 5358-5360. (Pubitemid 34983472)
18. Bird, A. P., (1986) CpG-rich islands and the function of DNA methylation. Nature 321, 209-213. (Pubitemid 16016411)
19. Antequera, F., and, A. Bird, (1993) CpG islands. EXS 64, 169-185.
20. Robertson, K. D., (2005) DNA methylation and human disease. Nat. Rev. Genet. 6, 597-610. (Pubitemid 41044297)
21. Chen, W. Y., X. Zeng, M. G. Carter, C. N. Morrell, R. W. Chiu-Yen, M. Esteller, D. N. Watkins, J. G. Herman, J. L. Mankowski, and, S. B. Baylin, (2003) Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat. Genet. 33, 197-202. (Pubitemid 36177074)
22. Tommasi, S., R. Dammann, Z. Zhang, Y. Wang, L. Liu, W. M. Tsark, S. P. Wilczynski, J. Li, M. You, and, G. P. Pfeifer, (2005) Tumor susceptibility of Rassf1a knockout mice. Cancer Res. 65, 92-98. (Pubitemid 40070799)
23. Jones, P. A., and, S. B. Baylin, (2007) The epigenomics of cancer. Cell 128, 683-692. (Pubitemid 46273572)
24. Toyota, M., and, J. P. Issa, (2005) Epigenetic changes in solid and hematopoietic tumors. Semin. Oncol. 32, 521-530.
25. Elovich, L., J. A. Crowell, and, J. R. Fay, (2003) The epigenome as a target for cancer chemoprevention. J. Natl Cancer Inst. 95, 1747-1757. (Pubitemid 38008897)
26. Choudhuri, S., Y. Cui, and, C. D. Klaassen, (2010) Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol. Appl. Pharmacol. 245, 378-393.
27. Ganesan, A., L. Nolan, S. J. Crabb, and, G. Packham, (2009) Epigenetic therapy: Histone acetylation, DNA methylation and anti-cancer drug discovery. Curr. Cancer Drug. Targets 9, 963-981.
28. Dalvai, M., and, K. Bystricky, (2010) The role of histone modifications and variants in regulating gene expression in breast cancer. J. Mammary Gland Biol. Neoplasia 15, 19-33.
29. Sharma, S., T. K. Kelly, and, P. A. Jones, (2010) Epigenetics in cancer. Carcinogenesis 31, 27-36.
30. Majid, S., N. Kikuno, J. Nelles, E. Noonan, Y. Tanaka, K. Kawamoto, H. Hirata, L. C. Li, H. Zhao, S. T. Okino, R. F. Place, D. Pookot, and, R. Dahiya, (2008) Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res. 68, 2736-2744. (Pubitemid 351556271)
31. Kikuno, N., H. Shiina, S. Urakami, K. Kawamoto, H. Hirata, Y. Tanaka, S. Majid, M. Igawa, and, R. Dahiya, (2008) Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int. J. Cancer 123, 552-560. (Pubitemid 351898412)
32. Acharya, M. R., A. Sparreboom, J. Venitz, and, W. D. Figg, (2005) Rational development of histone deacetylase inhibitors as anticancer agents: A review. Mol. Pharmacol. 68, 917-932. (Pubitemid 41345783)
33. Kim, D. H., M. Kim, and, H. J. Kwon, (2003) Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents. J. Biochem. Mol. Biol. 36, 110-119. (Pubitemid 36836262)
34. Mottet, D., and, V. Castronovo, (2008) Histone deacetylases: Target enzymes for cancer therapy. Clin. Exp. Metastasis 25, 183-189.
35. Katiyar, S. K., (2007) UV-induced immune suppression and photocarcinogenesis: Chemoprevention by dietary botanical agents. Cancer Lett. 255, 1-11. (Pubitemid 47212603)
36. Issa, J. P., N. Ahuja, M. Toyota, M. P. Bronner, and, T. A. Brentnall, (2001) Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 61, 3573-3577. (Pubitemid 32694963)
37. Sathyanarayana, U. G., A. Y. Moore, L. Li, A. Padar, K. Majumdar, V. Stastny, P. Makarla, M. Suzuki, J. D. Minna, Z. Feng, and, A. F. Gazdar, (2007) Sun exposure related methylation in malignant and non-malignant skin lesions. Cancer Lett. 245, 112-120. (Pubitemid 44959343)
38. Murao, K., Y. Kubo, N. Ohtani, E. Hara, and, S. Arase, (2006) Epigenetic abnormalities in cutaneous squamous cell carcinomas: Frequent inactivation of the RB1/p16 and p53 pathways. Br. J. Dermatol. 155, 999-1005. (Pubitemid 44564511)
39. Tommasi, S., M. F. Denissenko, and, G. P. Pfeifer, (1997) Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. Cancer Res. 57, 4727-4730. (Pubitemid 27468976)
40. Nandakumar, V., M. Vaid, T. O. Tollefsbol, and, S. K. Katiyar, (2011) Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice. Carcinogenesis 32, 597-604.
41. Jonason, A. S., S. Kunala, G. J. Price, R. J. Restifo, H. M. Spinelli, J. A. Persing, D. J. Leffell, R. E. Tarone, and, D. E. Brash, (1996) Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl Acad. Sci. USA 93, 14025-14029. (Pubitemid 26424239)
42. Mittal, A., C. Piyathilake, Y. Hara, and, S. K. Katiyar, (2003) Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: Relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia 5, 555-565. (Pubitemid 38045092)
43. Boyes, J., and, A. Bird, (1991) DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64, 1123-1134. (Pubitemid 121001199)
44. Grönniger, E., B. Weber, O. Heil, N. Peters, F. Stäb, H. Wenck, B. Korn, M. Winnefeld, and, F. Lyko, (2010) Aging and chronic sun exposure cause distinct epigenetic changes in human skin. PLoS Genet. 6 (5), e1000971.
45. Bardeesy, N., J. Morgan, M. Sinha, S. Signoretti, S. Srivastava, M. Loda, G. Merlino, and, R. A. DePinho, (2002) Obligate roles for p16Ink4a and p19Arf-p53 in the suppression of murine pancreatic neoplasia. Mol. Cell. Biol. 22, 635-643. (Pubitemid 34027507)
46. Magdinier, F., and, A. P. Wolffe, (2001) Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl Acad. Sci. USA 98, 4990-4995. (Pubitemid 32397070)
47. Cui, X., T. Wakai, Y. Shirai, K. Hatakeyama, and, S. Hirano, (2006) Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. Toxicol. Sci. 91, 372-381. (Pubitemid 43827290)
48. Allen, N. P., H. Donninger, M. D. Vos, K. Eckfeld, L. Hesson, L. Gordon, M. J. Birrer, F. Latif, and, G. J. Clark, (2007) RASSF6 is a novel member of the RASSF family of tumor suppressors. Oncogene 26, 6203-6211. (Pubitemid 47414375)
49. Craig, W. J., (1997) Phytochemicals: Guardians of our health. J. Am. Diet. Assoc. 97, S199-S204.
50. Craig, W. J., (1999) Health-promoting properties of common herbs. Am. J. Clin. Nutr. 70, S491-S499.
51. Yamakoshi, J., M. Saito, S. Kataoka, and, M. Kikuchi, (2002) Safety evaluation of proanthocyanidins-rich extract from grape seeds. Food Chem. Toxicol. 40, 599-607. (Pubitemid 34310425)
52. Mittal, A., C. A. Elmets, and, S. K. Katiyar, (2003) Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: Relationship to decreased fat and lipid peroxidation. Carcinogenesis 24, 1379-1388. (Pubitemid 37038827)
53. Sharma, S. D., and, S. K. Katiyar, (2010) Dietary grape seed proanthocyanidins inhibit UVB-induced cyclooxygenase-2 expression and other inflammatory mediators in UVB-exposed skin and skin tumors of SKH-1 hairless mice. Pharm. Res. 27, 1092-1102.
54. Sharma, S. D., S. M. Meeran, and, S. K. Katiyar, (2007) Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor-κB signaling in in vivo SKH-1 hairless mice. Mol. Cancer Ther. 6, 995-1005. (Pubitemid 46554569)
55. Katiyar, S. K., and, C. A. Elmets, (2001) Green tea polyphenolic antioxidants and skin photoprotection. Int. J. Oncol. 18, 1307-1313.
56. Katiyar, S. K., and, H. Mukhtar, (1996) Tea and chemoprevention of cancer: Epidemiologic and experimental studies. Int. J. Oncol. 8, 221-238.
57. Mantena, S. K., S. M. Meeran, C. A. Elmets, and, S. K. Katiyar, (2005) Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. J. Nutr. 135, 2871-2877. (Pubitemid 43156556)
58. Wang, Z. Y., M. T. Huang, T. Ferraro, C. Q. Wong, Y. R. Lou, K. R. Reuhl, M. Iatropoulos, C. S. Yang, and, A. H. Conney, (1992) Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res. 52, 1162-1170.
59. Wang, Z. Y., M. T. Huang, Y. R. Lou, J. G. Xie, K. R. Reuhl, H. L. Newmark, C. T. Ho, C. S. Yang, and, A. H. Conney, (1994) Inhibitory effect of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz(a) anthracene-initiated SKH-1 mice. Cancer Res. 54, 3428-3435.
60. Vayalil, P. K., C. A. Elmets, and, S. K. Katiyar, (2003) Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 24, 927-936. (Pubitemid 36748910)
61. Meeran, S. M., and, S. K. Katiyar, (2008) Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front. Biosci. 13, 2191-2202. (Pubitemid 351589245)
62. Meeran, S. M., S. Akhtar, and, S. K. Katiyar, (2009) Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. J. Invest. Dermatol. 129, 1258-1270.
63. Nichols, J. A., and, S. K. Katiyar, (2010) Skin photoprotection by natural polyphenols: Anti-inflammatory, anti-oxidant and DNA repair mechanisms. Arch. Dermatol. Res. 302, 71-83.
64. Nandakumar, V., M. Vaid, and, S. K. Katiyar, (2011) (-)-Epigallocatechin- 3-gallate reactivates silenced tumor suppressor genes by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 32, 537-544.
65. Rice, J. C., and, C. D. Allis, (2001) Histone methylation versus histone acetylation: New insights into epigenetic regulation. Curr. Opin. Cell Biol. 13, 263-273. (Pubitemid 32429490)
66. Nakayama, J., J. C. Rice, B. D. Strahl, A. D. Allis, and, S. I. Grewal, (2001) Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292, 110-113. (Pubitemid 32289138)
67. Druesne, N., A. Pagniez, C. Mayeur, M. Thomas, C. Cherbuy, P. H. Duée, P. Martel, and, C. Chaumontet, (2004) Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines. Carcinogenesis 25, 1227-1236. (Pubitemid 38968051)
68. King-Batoon, A., J. M. Leszczynska, and, C. B. Klein, (2008) Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ. Mol. Mutagen. 49, 36-45. (Pubitemid 351293011)
69. Fang, M. Z., Y. Wang, N. Ai, Z. Hou, Y. Sun, H. Lu, W. Welsh, and, C. S. Yang, (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63, 7563-7570. (Pubitemid 37466673)